BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 23845884)

  • 21. Stability-indicating HPLC method for the determination of cefquinome sulfate.
    Dołhań A; Jelilńska A; Manuszewska M
    Acta Pol Pharm; 2014; 71(2):249-54. PubMed ID: 25272644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution.
    Kasawar GB; Farooqui M
    J Pharm Biomed Anal; 2010 May; 52(1):19-29. PubMed ID: 20045275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a new stability indicating reversed phase liquid chromatographic method for the determination of prednisolone acetate and impurities in an ophthalmic suspension.
    Marley A; Stalcup AM; Connolly D
    J Pharm Biomed Anal; 2015 Jan; 102():261-6. PubMed ID: 25459922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analytical method development and validation for the analysis of verapamil hydrochloride and its related substances by using ultra perfomance liquid chromatography.
    Vijayabaskar S; Mahalingam V; Kalaivani
    J Pharm Biomed Anal; 2017 Apr; 137():189-195. PubMed ID: 28131058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a stability-indicating RP-LC method for the separation of a critical pair of impurities and their degradants in zafirlukast.
    Thiyagarajan TK; Abdul Hakeem JA; Baksam V
    J Chromatogr Sci; 2012; 50(10):945-52. PubMed ID: 22689905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid liquid chromatographic determination of itraconazole and its production impurities.
    Wharton M; Geary M; Sweetman P; Curtin L; O'Connor N
    J Chromatogr Sci; 2014 Mar; 52(3):187-94. PubMed ID: 23476029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPLC method for the determination of emtricitabine and related degradation substances.
    Hamarapurkar PD; Parate AN
    J Chromatogr Sci; 2013; 51(5):419-24. PubMed ID: 23051064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A validated stability indicating ultra performance liquid chromatographic method for determination of impurities in Esomeprazole magnesium gastro resistant tablets.
    Nalwade SU; Reddy VR; Rao DD; Morisetti NK
    J Pharm Biomed Anal; 2012 Jan; 57():109-14. PubMed ID: 21920688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
    Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K
    J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
    Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
    J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A validated stability-indicating normal phase LC method for clopidogrel bisulfate and its impurities in bulk drug and pharmaceutical dosage form.
    Durga Rao D; Kalyanaraman L; Sait SS; Venkata Rao P
    J Pharm Biomed Anal; 2010 May; 52(1):160-5. PubMed ID: 20074888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A stability indicating LC method for zolmitriptan.
    Rao BM; Srinivasu MK; Sridhar G; Kumar PR; Chandrasekhar KB; Islam A
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):503-9. PubMed ID: 15899567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability-indicating chromatographic methods for the determination of sertindole.
    El-Ragehy NA; Hassan NY; Abdelkawy M; Tantawy MA
    J Chromatogr Sci; 2014 Jul; 52(6):559-65. PubMed ID: 23733912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of duloxetine hydrochloride in the presence of process and degradation impurities by a validated stability-indicating RP-LC method.
    Raman NV; Harikrishna KA; Prasad AV; Reddy KR; Ramakrishna K
    J Pharm Biomed Anal; 2010 Mar; 51(4):994-7. PubMed ID: 20005658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability-indicating liquid chromatographic method for determination of saxagliptin and structure elucidation of the major degradation products using LC-MS.
    Abdel-Ghany MF; Abdel-Aziz O; Ayad MF; Tadros MM
    J Chromatogr Sci; 2015 Apr; 53(4):554-64. PubMed ID: 25060753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a stability-indicating RP-HPLC method for the determination of febuxostat (a xanthine oxidase inhibitor).
    Mukthinuthalapati MA; Bandaru SP; Bukkapatnam V; Mohapatro C
    J Chromatogr Sci; 2013; 51(10):931-8. PubMed ID: 23204011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RP-HPLC separation and ESI-MS, 1H, and 13C NMR characterization of forced degradants including process related impurities of carisbamate: method development and validation.
    Rao RN; Ramakrishna K; Sravan B; Santhakumar K
    J Pharm Biomed Anal; 2013 Apr; 77():49-54. PubMed ID: 23376724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
    Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
    J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability-indicating HPLC method for the determination of darunavir ethanolate.
    Reddy BV; Jyothi G; Reddy BS; Raman NV; Reddy KS; Rambabu C
    J Chromatogr Sci; 2013; 51(5):471-6. PubMed ID: 23097581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of stability-indicating HPLC method for determination of cefpirome sulfate.
    Zalewski P; Skibiński R; Cielecka-Piontek J; Bednarek-Rajewska K
    Acta Pol Pharm; 2014; 71(5):731-6. PubMed ID: 25362801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.